Ecto-5′-nucleotidase (CD73) is central to the generation of extracellular adenosine. Previous studies have highlighted a detrimental role for extracellular adenosine in cancer, as it dampens T cell–mediated immune responses. Here, we determined that, in contrast to other cancers, CD73 is markedly downregulated in poorly differentiated and advanced-stage endometrial carcinoma compared with levels in normal endometrium and low-grade tumors. In murine models, CD73 deficiency led to a loss of endometrial epithelial barrier function, and pharmacological CD73 inhibition increased in vitro migration and invasion of endometrial carcinoma cells. Given that CD73-generated adenosine is central to regulating tissue protection and physiology in normal tissues, we hypothesized that CD73-generated adenosine in endometrial carcinoma induces an innate reflex to protect epithelial integrity. CD73 associated with cell-cell contacts, filopodia, and membrane zippers, indicative of involvement in cell-cell adhesion and actin polymerization–dependent processes. We determined that CD73-generated adenosine induces cortical actin polymerization via adenosine A1 receptor (A1R) induction of a Rho GTPase CDC42–dependent conformational change of the actin-related proteins 2 and 3 (ARP2/3) actin polymerization complex member N-WASP. Cortical F-actin elevation increased membrane E-cadherin, β-catenin, and Na+K+ ATPase. Together, these findings reveal that CD73-generated adenosine promotes epithelial integrity and suggest why loss of CD73 in endometrial cancer allows for tumor progression. Moreover, our data indicate that the role of CD73 in cancer is more complex than previously described.
Jessica L. Bowser, Michael R. Blackburn, Gregory L. Shipley, Jose G. Molina, Kenneth Dunner Jr., Russell R. Broaddus
Title and authors | Publication | Year |
---|---|---|
Adenosinergic Signalling in Cervical Cancer Microenvironment
Iser IC, Bertoni AP, Beckenkamp LR, Consolaro ME, Maria-Engler SS, Wink MR |
Expert Reviews in Molecular Medicine | 2025 |
The metabolic role of the CD73/adenosine signaling pathway in HTR-8/SVneo cells: A Double-Edged Sword?
Song G, Zhang D, Zhu J, Wang A, Zhou X, Han TL, Zhang H |
Heliyon | 2024 |
Comprehensive pan-cancer analysis of CD73: Explore its association with prognosis and tumor immune microenvironment
Chen C, Liu S, Ma Y |
Heliyon | 2024 |
CD73 restrains mutant β-catenin oncogenic activity in endometrial carcinomas
Hirsch RM, Premsankar S, Kurnit KC, Chiou LF, Rabjohns EM, Lee HN, Broaddus RR, Vaziri C, Bowser JL |
bioRxiv | 2024 |
Identification of B Cell Subpopulations with Pro- and Anti-Tumorigenic Properties in an Immunocompetent Mouse Model of Head and Neck Squamous Cell Carcinoma
Sonntag M, Stanojevic S, Laban S, Schuler PJ, Hoffmann TK, Brunner C |
Cells | 2024 |
The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy
Kang C, Liu L, Wu C, Li L, Jia X, Xie W, Chen S, Wu X, Zheng H, Liu J, Li R, Zeng B |
Frontiers in immunology | 2023 |
5ʹ-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells
Shi E, Wu Z, Karaoglan BS, Schwenk-Zieger S, Kranz G, Abdul Razak N, Reichel CA, Canis M, Baumeister P, Zeidler R, Gires O |
Journal of biomedical science | 2023 |
A Vaccine against Cancer: Can There Be a Possible Strategy to Face the Challenge? Possible Targets and Paradoxical Effects
Zefferino R, Conese M |
Human vaccines | 2023 |
Unraveling the Intricacies of CD73/Adenosine Signaling: The Pulmonary Immune and Stromal Microenvironment in Lung Cancer
Saigí M, Mesía-Carbonell O, Barbie DA, Guillamat-Prats R |
Cancers | 2023 |
The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies
Wang L, Zhang J, Zhang W, Zheng M, Guo H, Pan X, Li W, Yang B, Ding L |
Acta pharmaceutica Sinica. B | 2023 |
Tumor Infiltration with CD20+CD73+ B Cells Correlates with Better Outcome in Colorectal Cancer
F Hansen, Z Wu, P David, A Mittelstädt, A Jacobsen, M Podolska, K Ubieta, M Brunner, D Kouhestani, I Swierzy, L Roßdeutsch, B Klösch, I Kutschick, S Merkel, A Denz, K Weber, C Geppert, R Grützmann, A Bénard, G Weber |
International journal of molecular sciences | 2022 |
4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR)—A Novel Oncometabolite Modulating Cancer-Endothelial Interactions in Breast Cancer Metastasis
Koszalka P, Kutryb-Zajac B, Mierzejewska P, Tomczyk M, Wietrzyk J, Serafin PK, Smolenski RT, Slominska EM |
International journal of molecular sciences | 2022 |
腺苷/A2AR信号通路阻断在肿瘤治疗中的应用
|
2022 | |
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain
Yegutkin GG, Boison D |
Pharmacological reviews | 2022 |
Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability
J Do, D Zwick, JD Kenyon, F Zhong, D Askew, AY Huang, WV Hof, M Finney, MJ Laughlin |
Scientific Reports | 2021 |
The elegant complexity of mammalian ecto-5′-nucleotidase (CD73)
KP Alcedo, JL Bowser, NT Snider |
Trends in Cell Biology | 2021 |
Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival
J Zhao, L Soto, H Wang, M Katz, L Prakash, M Kim, C Tzeng, J Lee, R Wolff, Y Huang, I Wistuba, A Maitra, H Wang |
Pancreatology | 2021 |
Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer
KC Kurnit, A Draisey, RC Kazen, C Chung, LH Phan, JB Harvey, J Feng, SS Xie, RR Broaddus, JL Bowser |
Cancer Letters | 2021 |
High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer
Y Bareche, S Pommey, M Carneiro, L Buisseret, I Cousineau, P Thebault, P Chrobak, L Communal, D Allard, SC Robson, AM Mes-Masson, D Provencher, R Lapointe, J Stagg |
Journal for ImmunoTherapy of Cancer | 2021 |
Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?
J Kotulová, M Hajdúch, P Džubák |
International journal of molecular sciences | 2021 |
Molecular subversion of Cdc42 signalling in cancer
NP Murphy, AM binti Ahmad Mokhtar, HR Mott, D Owen |
Biochemical Society Transactions | 2021 |
Characterization of the Endometrial MSC Marker Ectonucleoside Triphosphate Diphosphohydrolase-2 (NTPDase2/CD39L1) in Low- and High-Grade Endometrial Carcinomas: Loss of Stromal Expression in the Invasive Phenotypes
A Rodríguez-Martínez, C Trapero, A Vidal, JM Piulats, IG de Aranda, J Sévigny, ME Fernández-Montolí, J Ponce, X Matias-Guiu, M Martín-Satué |
Journal of Personalized Medicine | 2021 |
Loss of stromal CD73 expression plays a role in pathogenesis of polypoid endometriosis
AY Altay, E Yavuz, A Bayram, C Yasa, SE Akhan, S Topuz, S Onder |
Archives of Gynecology and Obstetrics | 2021 |
High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL)
JC Pritchett, ZZ Yang, HJ Kim, JC Villasboas, X Tang, S Jalali, JR Cerhan, AL Feldman, SM Ansell |
Leukemia | 2021 |
Targeting CD73 to augment cancer immunotherapy
M Roh, DA Wainwright, JD Wu, Y Wan, B Zhang |
Current Opinion in Pharmacology | 2020 |
Varied functions of immune checkpoints during cancer metastasis
A Safarzadeh, M Alizadeh, F Beyranvand, RF Jozaaee, K Hajiasgharzadeh, A Baghbanzadeh, A Derakhshani, A Argentiero, B Baradaran, N Silvestris |
Cancer Immunology, Immunotherapy | 2020 |
CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
JB Harvey, LH Phan, OE Villarreal, JL Bowser |
Frontiers in immunology | 2020 |
The adenosine pathway in immuno-oncology
B Allard, D Allard, L Buisseret, J Stagg |
Nature Reviews Clinical Oncology | 2020 |
The yin and yang functions of extracellular ATP and adenosine in tumor immunity
L Feng, Y Cai, M Zhu, L Xing, X Wang |
Cancer Cell International | 2020 |
CD73: A Promising Biomarker in Cancer Patients
R Turiello, A Pinto, S Morello |
Frontiers in pharmacology | 2020 |
Downregulation of CD73 associates with T cell exhaustion in AML patients
Y Kong, B Jia, C Zhao, DF Claxton, A Sharma, C Annageldiyev, JS Fotos, H Zeng, RF Paulson, KS Prabhu, H Zheng |
Journal of Hematology & Oncology | 2019 |
Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors
AM Chambers, S Matosevic |
Frontiers in Molecular Biosciences | 2019 |
CD73: an emerging checkpoint for cancer immunotherapy
S Chen, DA Wainwright, JD Wu, Y Wan, DE Matei, Y Zhang, B Zhang |
Immunotherapy | 2019 |
Tumor‐Selective Altered Glycosylation and Functional Attenuation of CD73 in Human Hepatocellular Carcinoma
KP Alcedo, A Guerrero, V Basrur, D Fu, ML Richardson, JS McLane, CC Tsou, AI Nesvizhskii, TH Welling, CB Lebrilla, CA Otey, HJ Kim, MB Omary, NT Snider |
Hepatology Communications | 2019 |
NT5E is associated with unfavorable prognosis and regulates cell proliferation and motility in gastric cancer
S Hu, F Meng, X Yin, C Cao, G Zhang |
Bioscience Reports | 2019 |
Impaired Expression of Ectonucleotidases in Ectopic and Eutopic Endometrial Tissue Is in Favor of ATP Accumulation in the Tissue Microenvironment in Endometriosis
C Trapero, A Vidal, ME Fernández-Montolí, B Coroleu, F Tresserra, P Barri, IG de Aranda, J Sévigny, J Ponce, X Matias-Guiu, M Martín-Satué |
International journal of molecular sciences | 2019 |
Adenosinergic signaling as a target for natural killer cell immunotherapy
J Wang, S Matosevic |
Journal of Molecular Medicine | 2018 |
The Hypoxia–Adenosine Link during Intestinal Inflammation
JL Bowser, LH Phan, HK Eltzschig |
Journal of immunology (Baltimore, Md. : 1950) | 2018 |
Targeting adenosine for cancer immunotherapy
RD Leone, LA Emens |
Journal for ImmunoTherapy of Cancer | 2018 |
The expression of the MSC-marker CD73 and of NF2/Merlin are correlated in meningiomas
E Kirches, T Steffen, N Waldt, E Hebert, D Pachow, A Wilisch-Neumann, G Keilhoff, T Schneider, WE Braunsdorf, JP Warnke, C Mawrin |
Journal of Neuro-Oncology | 2018 |
Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface
R Rahimova, S Fontanel, C Lionne, LP Jordheim, S Peyrottes, L Chaloin, A Schlessinger |
PLoS computational biology | 2018 |
Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association
G Kim, KC Kurnit, B Djordjevic, C Singh, MF Munsell, WL Wang, AJ Lazar, W Zhang, R Broaddus |
Modern Pathology | 2018 |
Regnase-1 controls colon epithelial regeneration via regulation of mTOR and purine metabolism
Y Nagahama, M Shimoda, G Mao, SK Singh, Y Kozakai, X Sun, D Motooka, S Nakamura, H Tanaka, T Satoh, K Maeda, S Akira |
Proceedings of the National Academy of Sciences | 2018 |
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
B Allard, MS Longhi, SC Robson, J Stagg |
Immunological Reviews | 2017 |
The hypoxia-adenosine link during inflammation
JL Bowser, JW Lee, X Yuan, HK Eltzschig |
Journal of applied physiology | 2017 |
Targeting immunosuppressive adenosine in cancer
D Vijayan, A Young, MW Teng, MJ Smyth |
Nature Reviews Cancer | 2017 |
Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor–Host Interaction and Therapeutic Perspectives
PA Mello, R Coutinho-Silva, LE Savio |
Frontiers in immunology | 2017 |
Purinergic Signalling: Therapeutic Developments
G Burnstock |
Frontiers in pharmacology | 2017 |
Heme oxygenase 1 governs the cytoskeleton at filopodia: pulling the brakes on the migratory capacity of prostate tumoral cells
A Paez, E Vazquez, G Gueron |
Cell Death Discovery | 2017 |
Extracellular purines, purinergic receptors and tumor growth
FD Virgilio, E Adinolfi |
Oncogene | 2016 |
Adenosine arrests breast cancer cell motility by A3 receptor stimulation
C Ledderose, MM Hefti, Y Chen, Y Bao, T Seier, L Li, T Woehrle, J Zhang, WG Junger |
Purinergic Signalling | 2016 |
MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis
Y Wang, L Hu, P Ji, F Teng, W Tian, Y Liu, D Cogdell, J Liu, AK Sood, R Broaddus, F Xue, W Zhang |
Journal of Hematology & Oncology | 2016 |
Heme oxygenase-1 in the forefront of a multi-molecular network that governs cell–cell contacts and filopodia-induced zippering in prostate cancer
AV Paez, C Pallavicini, F Schuster, MP Valacco, J Giudice, EG Ortiz, N Anselmino, E Labanca, M Binaghi, M Salierno, MA Martí, JH Cotignola, A Woloszynska-Read, L Bruno, V Levi, N Navone, ES Vazquez, G Gueron |
Cell Death and Disease | 2016 |
CD73s protection of epithelial integrity: Thinking beyond the barrier
JL Bowser, RR Broaddus |
Tissue Barriers | 2016 |
MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma
N Bonnin, E Armandy, J Carras, S Ferrandon, P Battiston-Montagne, M Aubry, S Guihard, D Meyronet, JP Foy, P Saintigny, S Ledrappier, A Jung, R Rimokh, C Rodriguez-Lafrasse, D Poncet |
Oncotarget | 2016 |